BMC Cancer · 2020 · 31 citations · 28 references
Life SciencesCell BiologyOncologyApoptosisCell SignalingSignal TransductionApoptosis In CancerCancer Cell SignalingMalignant NeoplasmsOncogenic Signaling PathwaysSignal Transduction In CancerTranscription Factor OncogenesAnnexin V AssaysAnnexin V ImagingApoptosis Signaling RegulationCell Fate DecisionsCellular ProliferationHepatocellular Carcinoma PathogenesisNfat SignalingViable Cell Count
Abstract Background Nuclear factor of activated T cells 2 (NFAT2) has been reported to regulate the development and malignancy of few tumors. In this study, we aimed to explore the effect of NFAT2 expression on cell fate of HepG2 cell and its potential mechanisms. Methods Firstly, the pcDNA3.1-NFAT2 plasmid was transfected into HepG2 cells to construct NFAT2 overexpressed HepG2 cells. Then, the chemical count kit-8 cell viability assay, Annexin V-FITC apoptosis detection, EdU labeling proliferation detection, transwell and wound healing experiments were performed. The expression of Egr2 and FasL, and the phosphorylation of AKT and ERK, after ionomycin and PMA co-stimulation, was detected, while the Ca 2+ mobilization stimulated by K + solution was determined. At last, the mRNA and protein expression of NFAT2, Egr2, FasL, COX-2 and c-myc in carcinoma and adjacent tissues was investigated. Results The NFAT2 overexpression suppressed the cell viability, invasion and migration capabilities, and promoted apoptosis of HepG2 cells. NFAT2 overexpression induced the expression of Egr2 and FasL and suppressed the phosphorylation of AKT and ERK. The sensitivity and Ca 2+ mobilization of HepG2 cells was also inhibited by NFAT2 overexpression. Compared with adjacent tissues, the carcinoma tissues expressed less NFAT2, Egr2, FasL and more COX-2 and c-myc. Conclusion The current study firstly suggested that NFAT2 suppressed the aggression and malignancy of HepG2 cells through inducing the expression of Egr2. The absence of NFAT2 and Egr2 in carcinoma tissues reminded us that NFAT2 may be a promising therapeutic target for hepatocellular carcinoma treatment.
28
Identification of a Putative Regulator of Early T Cell Activation Genes
Jeng‐Pyng Shaw, Paul J. Utz, David B. Durand et al. · Science · 1988 · 951 citations
The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells
Gustavo Martínez, Renata M. Pereira, Tarmo Äijö et al. · Immunity · 2015 · 856 citations · Full text